Table 2.
Age (years)
|
|||
---|---|---|---|
35-49 | 50-64 | 65-79 | |
Men | |||
No treatment | 320 | 325 | 283 |
Risk group: | |||
<5% | 263 (82) | 71 (22) | 0 |
5%-9% | 42 (13) | 124 (38) | 14 (5) |
10%-14% | 5 (2) | 55 (17) | 54 (19) |
15%-19% | 4 (1) | 36 (11) | 65 (23) |
⩾20% | 6 (2) | 39 (12) | 150 (53) |
Mean risk (% risk next 5 years) | 3.4 | 10.3 | 19.6 |
Treatment | 14 | 49 | 103 |
Risk group: | |||
<5% | 7 (50) | 0 | 0 |
5%-9% | 6 (43) | 8 (16) | 1 (1) |
10%-14% | 0 | 21 (43) | 8 (8) |
15%-19% | 0 | 7 (14) | 11 (11) |
⩾20% | 1 (7) | 13 (27) | 83 (80) |
Mean risk (% risk next 5 years) | 4.9 |
14.3 |
23.6 |
Women | |||
No treatment | 315 | 293 | 258 |
Risk group: | |||
<5% | 309 (98) | 190 (65) | 31 (12) |
5%-9% | 6 (2) | 67 (23) | 90 (35) |
10%-14% | 0 | 21 (7) | 67 (26) |
15%-19% | 0 | 6 (2) | 29 (11) |
⩾20% | 0 | 9 (3) | 41 (16) |
Mean risk (% risk next 5 years) | 1.1 | 5.4 | 11.7 |
Treatment | 7 | 60 | 131 |
Risk group: | |||
<5% | 6 (86) | 10 (17) | 0 |
5%-9% | 1 (14) | 22 (37) | 16 (12) |
10%-14% | 0 | 13 (21) | 31 (24) |
15%-19% | 0 | 7 (12) | 21 (16) |
⩾20% | 0 | 8 (13) | 63 (48) |
Mean risk (% risk next 5 years) | 2.0 | 9.6 | 16.9 |